Within this context, targeting Bcl2 family attracted our interest given the evidence that inhibition of MDM2 and Bcl2 protein function synergistically induce apoptosis in cancer cells (Kojima et al., 2006; Kracikova et al., 2013). The gene discussed is BCL2; the disease is cancer.